HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kuai Yu Selected Research

Proteins (Proteins, Gene)

4/2024Characterization of humoral immune responses against SARS-CoV-2 accessory proteins in infected patients and mouse model.
10/2023Myc rearrangement and concurrent high protein expression of C-Myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma.
11/2020PPM1G restricts innate immune signaling mediated by STING and MAVS and is hijacked by KSHV for immune evasion.
6/2014The Ca(2+) -activated Cl(-) channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis.
5/2009Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kuai Yu Research Topics

Disease

11Neoplasms (Cancer)
01/2024 - 05/2009
6Macular Degeneration (Age-Related Maculopathy)
03/2010 - 10/2007
5Vitelliform Macular Dystrophy
12/2013 - 11/2006
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024 - 10/2023
2Hypertension (High Blood Pressure)
08/2023 - 11/2013
2Asthma (Bronchial Asthma)
08/2023 - 11/2013
2Infections
01/2023 - 06/2019
2Genetic Predisposition to Disease (Genetic Predisposition)
08/2022 - 03/2022
2Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 01/2019
2Acute Coronary Syndrome
01/2021 - 01/2019
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 12/2017
2Ischemia
01/2017 - 02/2015
1COVID-19
04/2024
1Disease Progression
04/2024
1Chronic Obstructive Pulmonary Disease (COPD)
08/2023
1Multiple Myeloma
08/2023
1Chromosome Aberrations (Chromosome Abnormalities)
08/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Hearing Loss (Hearing Impairment)
01/2023
1Virus Diseases (Viral Diseases)
01/2023
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022
1Leukemia
12/2022
1Spinal Cord Injuries (Spinal Cord Injury)
03/2022
1Immune System Diseases (Immune Disorders)
03/2022
1Vascular Diseases (Vascular Disease)
11/2020
1Stroke (Strokes)
11/2020
1Bites and Stings (Sting)
11/2020
1Rhabdomyosarcoma
01/2020
1Necrosis
06/2019
1Type 2L Limb-Girdle Muscular Dystrophy
11/2018
1Heart Failure
01/2017
1Brain Edema (Cerebral Edema)
01/2017
1Coronary Disease (Coronary Heart Disease)
01/2017
1Ischemic Stroke
01/2017
1Brain Infarction
01/2017

Drug/Important Bio-Agent (IBA)

8BestrophinsIBA
12/2013 - 11/2006
5Proteins (Proteins, Gene)FDA Link
04/2024 - 05/2009
5Biomarkers (Surrogate Marker)IBA
01/2024 - 06/2014
5Chloride Channels (Chloride Channel)IBA
02/2015 - 11/2006
2InterferonsIBA
01/2023 - 01/2020
2MetalsIBA
01/2023 - 08/2022
2ArsenicIBA
08/2022 - 03/2022
2AntigensIBA
01/2022 - 01/2020
2CopperIBA
01/2021 - 09/2005
2CytokinesIBA
01/2020 - 01/2019
1LuciferasesIBA
04/2024
1AntibodiesIBA
04/2024
1Immunoglobulins (Immunoglobulin)IBA
01/2024
1MucinsIBA
01/2024
1Apoptosis Regulatory ProteinsIBA
01/2024
1AnthelminticsIBA
08/2023
1NiclosamideFDA Link
08/2023
1AlbuminsIBA
08/2023
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2023
1CreatinineIBA
08/2023
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2023
1Complement C3 (C3 Complement)IBA
01/2023
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2023
1UbiquitinIBA
01/2023
1Small Interfering RNA (siRNA)IBA
12/2022
1CurcuminIBA
12/2022
1Caspase 1 (ICE Protease)IBA
12/2022
1Transcription Factors (Transcription Factor)IBA
12/2022
1InflammasomesIBA
12/2022
1MetalloidsIBA
08/2022
1SeleniumIBA
08/2022
1HomocysteineIBA
08/2022
1Complement System Proteins (Complement)IBA
03/2022
1VaccinesIBA
01/2022
1Neoplasm Antigens (Tumor Antigens)IBA
01/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Therapeutic UsesIBA
01/2022
1Small Cytoplasmic RNAIBA
01/2022
1Diacylglycerol KinaseIBA
01/2021
1Carbon MonoxideIBA
11/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Single-Chain AntibodiesIBA
01/2020
1Chimeric Antigen ReceptorsIBA
01/2020
1Interleukin-2 (IL2)IBA
01/2020
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2020
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2020
1Acute-Phase Proteins (Acute-Phase Protein)IBA
06/2019
1Fatty Acid-Binding ProteinsIBA
06/2019
1OsteopontinIBA
01/2019
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2019
1GlucocorticoidsIBA
01/2019
1CarcinogensIBA
01/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2018
1Carbon Nanotubes (Carbon Nanotube)IBA
01/2018
1LipidsIBA
12/2017
1Neuroprotective AgentsIBA
01/2017
1Urea (Carbamide)FDA LinkGeneric
01/2017
1NitrogenIBA
01/2017
1LigandsIBA
01/2017
1EphA2 ReceptorIBA
01/2017
1Anoctamin-1IBA
06/2014

Therapy/Procedure

4Therapeutics
03/2022 - 01/2020
3Immunotherapy
01/2023 - 01/2021
1Stem Cell Transplantation
03/2022